No menu items!

Tag: anetumab ravtansine

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen...

Popular

Torrevieja Picks Safer, Parallel Route for Hospital Pedestrian Path

The Torrevieja City Council has chosen a new route...

Spain in Unison over Facemasks as it Adopts New Plan for Winter Respiratory Viruses

Spain’s Ministry of Health and regional governments have agreed...

Residents of Casas del Cura Demand Murcia Council Restore Water Supply

Residents of the Casas del Cura residential area, near...

Julia Sales Cuenca Wins Orihuela Christmas Story Contest!

This year’s 18th Christmas Story Contest brought together 65...